20 results
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
C.diff - Clostridioides ... Tx Management (IDSA ... Bezlotoxumab 10 mg/kg IV ... IDSA 2021 CDI ... #Cdiff #Clostridioides
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Infections in HIV-AIDS ... Patients with CD4 ... to 5 mg/kg/day IV ... Penicilliosis #IDSA
Pulmonary Infections in HIV-AIDS
Bacterial: 
 • No organism identified, Strep pneumoniae, H. influenzae, S.aureus, Streptococcus Grp
Infections in HIV-AIDS ... < 200: CMV, HSV ... ) Fungal: • CD4 ... Parasitic: • CD4 ... chest scan), CBC/diff
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Infections in HIV-AIDS ... PO (or 400 mg IV ... difficile Infection (CDI ... Enteric #Bacterial #IDSA
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... belli Infection in HIV-AIDS ... Patients with CD4 ... times weekly (CI ... IsosporaBelli #IDSA
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... Leishmaniasis in HIV-AIDS ... amphotericin B 2–4 mg/kg IV ... leishmaniasis and CD4 ... amphotericin B 2–4 mg/kg IV
A proposed management algorithm for CDI in patients with inflammatory bowel disease. *Severe-complicated CDI is defined
algorithm for CDI ... Severe-complicated CDI ... uncomplicated CDI ... IV, intravenously ... #CDI #CDiff #clostridiumdifficile
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
IDSA Recommendations ... Pneumonia (PCP) in HIV-AIDS ... cells/mm3 and HIV ... regardless of HIV ... Pneumocystis #Pneumonia #IDSA
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... Disease (MCD) in HIV-AIDS ... • Since low CD4 ... and uncontrolled HIV ... KaposiSarcoma #Castlemans #IDSA
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... Coccidiodomycosis in HIV-AIDS ... positive serology and CD4 ... 0.7–1.0 mg/kg IV ... Coccidiodomycosis #IDSA